92 related articles for article (PubMed ID: 3003560)
1. Expression of beta-adrenergic receptors in synchronous and asynchronous S49 lymphoma cells. II. Relationship between receptor number and response.
Mahan LC; Insel PA
Mol Pharmacol; 1986 Jan; 29(1):16-22. PubMed ID: 3003560
[TBL] [Abstract][Full Text] [Related]
2. Expression of beta-adrenergic receptors in synchronous and asynchronous S49 lymphoma cells. I. Receptor metabolism after irreversible blockade of receptors and in cells traversing the cell division cycle.
Mahan LC; Insel PA
Mol Pharmacol; 1986 Jan; 29(1):7-15. PubMed ID: 2868411
[TBL] [Abstract][Full Text] [Related]
3. Expression and characterization of the long and short splice variants of GS alpha in S49 cyc- cells.
O'Donnell JK; Sweet RW; Stadel JM
Mol Pharmacol; 1991 Jun; 39(6):702-10. PubMed ID: 1646945
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a bromoacetylated derivative of pindolol as a high affinity, irreversible beta adrenergic antagonist in cultured cells.
Jasper JR; Motulsky HJ; Insel PA
J Pharmacol Exp Ther; 1988 Mar; 244(3):820-4. PubMed ID: 2908047
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of ornithine decarboxylase and S-adenosylmethionine decarboxylase activities of S49 lymphoma cells by agents increasing cyclic AMP.
Honeysett JM; Insel PA
J Cyclic Nucleotide Res; 1981; 7(5):321-32. PubMed ID: 6284819
[TBL] [Abstract][Full Text] [Related]
6. Distinctions in beta-adrenergic receptor interactions with the magnesium-guanine nucleotide coupling proteins in turkey erythrocyte and S49 lymphoma membranes.
Vauquelin G; Cech SY; André C; Strosberg AD; Maguire ME
J Cyclic Nucleotide Res; 1982; 8(3):149-62. PubMed ID: 6300206
[TBL] [Abstract][Full Text] [Related]
7. Beta adrenergic receptor subtypes in the atria: evidence for close coupling of beta-1 and beta-2 adrenergic receptors to adenylate cyclase.
Liang BT; Molinoff PB
J Pharmacol Exp Ther; 1986 Sep; 238(3):886-92. PubMed ID: 2875173
[TBL] [Abstract][Full Text] [Related]
8. Colchicine and cytochalasin B enhance cyclic AMP accumulation via postreceptor actions.
Jasper JR; Post SR; Desai KH; Insel PA; Bernstein D
J Pharmacol Exp Ther; 1995 Aug; 274(2):937-42. PubMed ID: 7636757
[TBL] [Abstract][Full Text] [Related]
9. Amplification of cyclic AMP generation reveals agonistic effects of certain beta-adrenergic antagonists.
Jasper JR; Michel MC; Insel PA
Mol Pharmacol; 1990 Jan; 37(1):44-9. PubMed ID: 1967818
[TBL] [Abstract][Full Text] [Related]
10. Agonist-induced changes in the properties of beta-adrenergic receptors on intact S49 lymphoma cells. Time-dependent changes in the affinity of the receptor for agonists.
Hoyer D; Reynolds EE; Molinoff PB
Mol Pharmacol; 1984 Mar; 25(2):209-18. PubMed ID: 6142414
[TBL] [Abstract][Full Text] [Related]
11. Beta-adrenergic receptor levels and function after growth of S49 lymphoma cells in low concentrations of epinephrine.
Proll MA; Clark RB; Goka TJ; Barber R; Butcher RW
Mol Pharmacol; 1992 Jul; 42(1):116-22. PubMed ID: 1321952
[TBL] [Abstract][Full Text] [Related]
12. Comparisons of the combined contributions of agonist binding frequency and intrinsic efficiency to receptor-mediated activation of adenylate cyclase.
Stickle D; Barber R
Mol Pharmacol; 1991 Aug; 40(2):276-88. PubMed ID: 1678853
[TBL] [Abstract][Full Text] [Related]
13. beta-Adrenergic receptors and adenylate cyclase activity in murine lymphoid cell lines.
Staehelin M; Müller P; Portenier M; Harris AW
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(1):55-64. PubMed ID: 2984265
[TBL] [Abstract][Full Text] [Related]
14. Desensitization of catecholamine-stimulated adenylate cyclase and down-regulation of beta-adrenergic receptors in rat glioma C6 cells. Role of cyclic AMP and protein synthesis.
Zaremba TG; Fishman PH
Mol Pharmacol; 1984 Sep; 26(2):206-13. PubMed ID: 6207420
[TBL] [Abstract][Full Text] [Related]
15. Chronic somatostatin treatment induces enhanced forskolin-stimulated cAMP accumulation in wild-type S49 mouse lymphoma cells but not in protein kinase-deficient mutants.
Thomas JM; Hoffman BB
Mol Pharmacol; 1989 Jan; 35(1):116-24. PubMed ID: 2563303
[TBL] [Abstract][Full Text] [Related]
16. Phorbol ester-induced augmentation and inhibition of epinephrine-stimulated adenylate cyclase in S49 lymphoma cells.
Johnson JA; Goka TJ; Clark RB
J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(3):199-215. PubMed ID: 3020100
[TBL] [Abstract][Full Text] [Related]
17. Ca2+ inhibition of beta-adrenergic receptor- and forskolin-stimulated cAMP accumulation in C6-2B rat glioma cells is independent of protein kinase C.
Debernardi MA; Munshi R; Brooker G
Mol Pharmacol; 1993 Mar; 43(3):451-8. PubMed ID: 8383803
[TBL] [Abstract][Full Text] [Related]
18. Growth of S49 cells in low concentrations of beta-adrenergic agonists causes desensitization.
Barber R; Goka TJ; Butcher RW
Mol Pharmacol; 1989 Sep; 36(3):459-64. PubMed ID: 2550779
[TBL] [Abstract][Full Text] [Related]
19. Beta-adrenergic receptor overexpression in the fetal rat: distribution, receptor subtypes, and coupling to adenylate cyclase activity via G-proteins.
Slotkin TA; Lau C; Seidler FJ
Toxicol Appl Pharmacol; 1994 Dec; 129(2):223-34. PubMed ID: 7992312
[TBL] [Abstract][Full Text] [Related]
20. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
Zeiders JL; Seidler FJ; Slotkin TA
J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
